JMP Securities Reaffirms “Market Outperform” Rating for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market outperform” rating reiterated by equities researchers at JMP Securities in a research report issued on Tuesday,Benzinga reports. They presently have a $113.00 target price on the stock. JMP Securities’ target price points to a potential upside of 64.18% from the stock’s previous close.

A number of other brokerages also recently issued reports on USPH. StockNews.com downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Thursday, April 17th. Barrington Research decreased their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, March 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $109.00.

U.S. Physical Therapy Price Performance

USPH opened at $68.83 on Tuesday. The stock’s 50-day moving average price is $75.33 and its 200 day moving average price is $84.49. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $108.14. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 73.22, a PEG ratio of 3.54 and a beta of 1.38. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. As a group, sell-side analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of USPH. Bessemer Group Inc. raised its stake in shares of U.S. Physical Therapy by 4.4% during the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company’s stock worth $357,000 after purchasing an additional 208 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in U.S. Physical Therapy by 15.7% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 25,588 shares of the company’s stock valued at $1,852,000 after buying an additional 3,464 shares during the period. Precision Wealth Strategies LLC raised its position in U.S. Physical Therapy by 6.6% during the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock worth $221,000 after buying an additional 189 shares during the last quarter. Albert D Mason Inc. lifted its stake in shares of U.S. Physical Therapy by 2.5% in the 1st quarter. Albert D Mason Inc. now owns 10,856 shares of the company’s stock worth $786,000 after acquiring an additional 260 shares during the period. Finally, Fifth Third Bancorp boosted its holdings in shares of U.S. Physical Therapy by 34.6% in the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock valued at $75,000 after acquiring an additional 265 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.